Key result
In anaesthetized rats, platelet activating factor decreased mean arterial blood pressure by ~60 mmHg, a depressor response significantly mediated by endothelium-derived hyperpolarizing factor.
Answers are grounded in this paper and cite their sources.
In a rat model, endothelium-derived hyperpolarizing factor (EDHF) appears to play a significant role in the blood pressure-lowering effects of platelet activating factor.
In anaesthetized rats, platelet activating factor (PAF; 1 microg kg(-1)) decreased mean arterial blood pressure by around 60 mmHg (n=18). This depressor response was completely blocked by the PAF antagonist, CV-6209 (1 mg kg(-1)), indicating the role of PAF-specific receptor in the response. 2. N(G)-nitro-L-arginine methyl ester (L-NAME; 50 mg kg(-1)), an NO synthase inhibitor, profoundly elevated systemic blood pressure (n=19), indicating an important role of NO in the basal blood pressure regulation. The depressor response to PAF (1 microg kg(-1)) normalized against that to sodium nitroprusside (SNP) (10 microg kg(-1)) was not substantially different between rats treated without and with L-NAME (n=4). In contrast, the depressor effect of acetylcholine (0.03 - 1.0 microg kg(-1)) normalized against that of SNP (10 microg kg(-1)) was significantly attenuated by L-NAME (n=5). 3. Charybdotoxin (0.4 mg kg(-1)) plus apamin (0.2 mg kg(-1)) significantly attenuated the depressor response to PAF (1 microg kg(-1)) (n=5) without affecting the blood pressure change due to SNP (1 mg kg(-1)) (n=3). Charybdotoxin (0.4 mg kg(-1)) (n=4) or apamin (0.2 mg kg(-1)) (n=4) alone did not affect the PAF-induced depressor response. 4. These findings suggest that EDHF may make a significant contribution to the depressor response to PAF in rats. Although NO plays the determinant role in the basal blood pressure regulation, its contribution to PAF-produced depressor response seems to be less as compared with that to the depressor response to acetylcholine.
No takes yet. Share an insight, caveat, or question.
Tanaka et al. (2000) studied this question. Platelet activating factor (PAF) vs. Baseline / CV-6209 / L-NAME / Charybdotoxin + apamin was evaluated on Mean arterial blood pressure. In anaesthetized rats, platelet activating factor decreased mean arterial blood pressure by ~60 mmHg, a depressor response significantly mediated by endothelium-derived hyperpolarizing factor.
Synapse has enriched 10 related papers. Consider them for comparative context: